CASE REPORT
Progressive spastic paraparesis in a young male
 
More details
Hide details
1
Department of Neurology and Neurosurgery, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Poland
CORRESPONDING AUTHOR
Beata Zwiernik   

Department of Neurology and Neurosurgery, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Warszawska 30, 10-082 Olsztyn, Poland. Tel.: +4889 524 53 84.
Submission date: 2017-04-27
Acceptance date: 2017-09-26
Online publication date: 2018-03-05
Publication date: 2019-11-17
 
Pol. Ann. Med. 2018;25(1):134–138
 
KEYWORDS
CONFLICT OF INTEREST
None declared.
 
REFERENCES (26)
1.
Moser HW. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain. 1997;120(Pt 8):1485–1508. https://doi.org/10.1093/brain/....
 
2.
Aubourg P. [Adrénoleucodystrophie liée à l’X]. Annales d’Endocrinologie. 2007;68: 317–324 [in French]. https://doi.org/10.1016/j.ando....
 
3.
Bezman L, Moser HW. Incidence of X-linked adrenoleukodystrophy and the relative frequency of its phenotypes. Am J Med Genet. 1998;76(5):415–419. https://doi.org/10.1002/(SICI)...<415::AID-AJMG9>3.0.CO;2-L.
 
4.
Mosser J, Lutz Y, Stoeckel ME, et al. The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. Hum Mol Genet.1994;3(2):265–271. https://doi.org/10.1093/hmg/3.....
 
5.
Kemp S, Pujol A, Waterham H, et al. ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations. Hum Mutat. 2001;18(6):499–515. https://doi.org/10.1002/humu.1....
 
6.
Kemp S, Wanders R. Biochemical aspects of X-linked adrenoleukodystrophy. Brain Pathol. 2010;20(4):831–837. https://doi.org/10.1111/j.1750....
 
7.
Hein S, Schönfeld P, Kahlert S, Reiser G. Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture. Hum Mol Genet. 2008;17(12):1750–1761. https://doi.org/10.1093/hmg/dd....
 
8.
Whitcomb RW, Linehan WM, Knazek RA. Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro. J Clin Invest. 1988;81(1):185–188. https://doi.org/10.1172/JCI113....
 
9.
Berger J, Forss-Petter S, Eichler F. Pathophysiology of X-linked adrenoleukodystrophy. Biochimie. 2014;98:135–142. https://doi.org/10.1016/j.bioc....
 
10.
Moser HW, Mahmood A, Raymond GV. X-linked adrenoleukodystrophy. Nat Clin Pract Neurol. 2007;3(3):140–151. https://doi.org/10.1038/ncpneu....
 
11.
Mosser J, Douar AM, Sarde CO, et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature. 1993;361(6414):726-730. https://doi.org/10.1038/361726....
 
12.
Neuromuscular Disease Center. Washington University, St. Louis, MO USA [online database] Familial Spinal Cord Syndromes X-linked/Adrenomyeloneuropathy. Available at: http://neuromuscular.wustl.edu....
 
13.
Engelen M, Kemp S, de Visser M, et al. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis. 2012;7:51. https://doi.org/10.1186/1750-1....
 
14.
Brennemann W, Köhler W, Zierz S, Klingmüller D. Testicular dysfunction in adrenomyeloneuropathy. Eur J Endocrinol. 1997;137(1):34–43. https://doi.org/10.1530/eje.0.....
 
15.
Moser HW, Moser AB, Naidu S, Bergin A. Clinical aspects of adrenoleukodystrophy and adrenomyeloneuropathy. Dev Neurosci. 1991;13(4–5):254–261. https://doi.org/10.1159/000112....
 
16.
Höftberger R, Kunze M, Weinhofer I, et al. Distribution and cellular localization of adrenoleukodystrophy protein in human tissues: implications for X-linked adrenoleukodystrophy. Neurobiol Dis. 2007;28(2):165–174. https://doi.org/10.1016/j.nbd.....
 
17.
Edwin D, Speedie L, Naidu S, Moser H. Cognitive impairment in adult-onset adrenoleukodystrophy. Mol Chem Neuropathol. 1990;12(3):167–176. https://doi.org/10.1007/BF0315....
 
18.
Kemp S, Bergerc J, Aubourgd P. X-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological. Biochim Biophys Acta. 2012;1822(9):1465–1474. https://doi.org/10.1016/j.bbad....
 
19.
van Geel BM, Assies J, Weverling GJ, Barth PG. Predominance of the adrenomyeloneuropathy phenotype of X-linked adrenoleukodystrophy in The Netherlands: a survey of 30 kindreds. Neurology. 1994;44(12):2343–2346. https://doi.org/10.1212/WNL.44....
 
20.
Engelen M, Kemp S. Facts on ALD April 15th, 2016. ALD database. http://www.x-ald.nl/clinical-d....
 
21.
Cappa M, Bizzarri C, Giannone G, Aiello C, Di Biase A. Is subclinical adrenal failure in adrenoleukodystrophy/adrenomyeloneuropathy reversible? J Endocrinol Invest. 2011;34(10):753–756.
 
22.
Abel A, Danek A, Borasio GD, Witt TN. [X chromosomal bulbospinal neuropathy (X-BSN, Kennedy syndrome): an illness with repetitive triplet sequences. Case report, differential diagnosis and molecular genetics aspects]. Nervenarzt. 1996;67(12):1011–1019 [in German]. https://doi.org/10.1007/s00115....
 
23.
Tuck RR, O’Neill BP, Gharib H, Mulder DW. Familial spastic paraplegia with Kallmann’s syndrome. J Neurol Neurosurg Psychiatry. 1983;46(7):671–674. https://doi.org/10.1136/jnnp.4....
 
24.
Moser HW, Raymond GV, Lu SE, et al. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo’s oil. Arch Neurol. 2005;62(7):1073–1080. https://doi.org/10.1001/archne....
 
25.
Engelen M, Ofman R, Dijkgraaf MG, et al. Lovastatin in X-linked adrenoleukodystrophy. N Eng J Med. 2010;362(3):276–277. https://doi.org/10.1056/NEJMc0....
 
26.
Mahmood A, Raymond G, Dubey P, Peters C, Moser HW. Survival analysis of haematopoietic cell transplantation for childhood cerebral X-linked adrenoleukodystrophy: a comparison study. Lancet Neurol. 2007;6(8):687–692. https://doi.org/10.1016/S1474-....